Skip to main content
Log in

Industry wary of NIH consultancy moratorium

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Time is needed to assess how appropriate is the NIH proposal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Conflicts at the NIH (cont.)

Panel slated for leniency over study of NIH consulting roles

NIH urged to rewrite rules on consultancies

Related external links

House Subcommittee on Oversight and Investigations

Biotechnology Industry Organization

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, J. Industry wary of NIH consultancy moratorium. Nat Biotechnol 22, 1331–1332 (2004). https://doi.org/10.1038/nbt1104-1331

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1104-1331

  • Springer Nature America, Inc.

This article is cited by

Navigation